| 摘要 |
Compounds represented by formula I: wherein R<SUP>1 </SUP>is H, halogen, (C<SUB>1-4</SUB>)alkyl, O(C<SUB>1-4</SUB>)alkyl, and haloalkyl; R<SUP>2 </SUP>is H or (C<SUB>1-4</SUB>)alkyl; R<SUP>3 </SUP>is H or (C<SUB>1-4</SUB>)alkyl; R<SUP>4 </SUP>is (C<SUB>1-4</SUB>)alkyl, (C<SUB>1-4</SUB>)alkyl(C<SUB>3-7</SUB>)cycloalkyl, or (C<SUB>3-7</SUB>)cycloalkyl; and Q is a fused phenyl-5 or 6-membered saturated heterocycle having one to two heteroatoms selected from O and N, said Q being optionally substituted with hydroxy, or (C<SUB>1-4</SUB>)alkyl which in turn maybe optionally substituted with pyridinyl-N-oxide or C(O)OR wherein R is H or (C<SUB>1-4</SUB>)alkyl; or a salt thereof. The compounds have inhibitory activity against Wild Type, and single and double mutants strains, of HIV.
|
